Titre : Catéchine

Catéchine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lymphatic Metastasis

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment mesurer les niveaux de catéchines dans le corps ?

Les niveaux de catéchines peuvent être mesurés par des analyses sanguines ou urinaires.
Catéchines Analyse sanguine
#2

Quels tests sont utilisés pour évaluer l'impact des catéchines ?

Des tests cliniques et des études d'observation sont utilisés pour évaluer leur impact.
Catéchines Études cliniques

Symptômes 2

#1

Quels sont les effets secondaires des catéchines ?

Les effets secondaires peuvent inclure des maux d'estomac, des nausées ou des maux de tête.
Effets secondaires Catéchines
#2

Les catéchines provoquent-elles des allergies ?

Les allergies aux catéchines sont rares, mais peuvent survenir chez certaines personnes.
Allergies Catéchines

Prévention 2

#1

Les catéchines aident-elles à prévenir les maladies cardiaques ?

Oui, elles peuvent réduire le risque de maladies cardiaques en améliorant la santé vasculaire.
Maladies cardiaques Prévention
#2

Comment intégrer les catéchines dans l'alimentation ?

Consommer du thé vert, des fruits et des légumes riches en catéchines est recommandé.
Alimentation Catéchines

Traitements 2

#1

Les catéchines peuvent-elles traiter des maladies ?

Elles sont étudiées pour leur potentiel dans le traitement de maladies comme le cancer.
Traitement du cancer Catéchines
#2

Comment les catéchines aident-elles à la perte de poids ?

Elles peuvent augmenter le métabolisme et favoriser la combustion des graisses.
Perte de poids Métabolisme

Complications 2

#1

Les catéchines peuvent-elles interagir avec des médicaments ?

Oui, elles peuvent interagir avec certains médicaments, notamment les anticoagulants.
Interactions médicamenteuses Catéchines
#2

Quels risques sont associés à une consommation excessive de catéchines ?

Une consommation excessive peut entraîner des problèmes hépatiques ou des troubles digestifs.
Toxicité Catéchines

Facteurs de risque 2

#1

Qui devrait éviter les catéchines ?

Les personnes ayant des problèmes hépatiques ou des allergies doivent être prudentes.
Facteurs de risque Catéchines
#2

Les femmes enceintes peuvent-elles consommer des catéchines ?

Elles doivent consulter un médecin avant de consommer des catéchines en grande quantité.
Grossesse Catéchines
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Catéchine : Questions médicales les plus fréquentes", "headline": "Catéchine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Catéchine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-14", "dateModified": "2025-02-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Catéchine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavonoïdes", "url": "https://questionsmedicales.fr/mesh/D005419", "about": { "@type": "MedicalCondition", "name": "Flavonoïdes", "code": { "@type": "MedicalCode", "code": "D005419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450" } } }, "about": { "@type": "MedicalCondition", "name": "Catéchine", "alternateName": "Catechin", "code": { "@type": "MedicalCode", "code": "D002392", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jae Sik Yu", "url": "https://questionsmedicales.fr/author/Jae%20Sik%20Yu", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea." } }, { "@type": "Person", "name": "Ki Hyun Kim", "url": "https://questionsmedicales.fr/author/Ki%20Hyun%20Kim", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea." } }, { "@type": "Person", "name": "Masaharu Shin-Ya", "url": "https://questionsmedicales.fr/author/Masaharu%20Shin-Ya", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } }, { "@type": "Person", "name": "Eriko Ohgitani", "url": "https://questionsmedicales.fr/author/Eriko%20Ohgitani", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } }, { "@type": "Person", "name": "Masaya Kawamoto", "url": "https://questionsmedicales.fr/author/Masaya%20Kawamoto", "affiliation": { "@type": "Organization", "name": "Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Radiomics model based on features of axillary lymphatic nodes to predict axillary lymphatic node metastasis in breast cancer.", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35869750", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/mp.15873" } }, { "@type": "ScholarlyArticle", "name": "Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.", "datePublished": "2023-07-06", "url": "https://questionsmedicales.fr/article/37415190", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13046-023-02714-0" } }, { "@type": "ScholarlyArticle", "name": "CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis.", "datePublished": "2023-07-06", "url": "https://questionsmedicales.fr/article/37409440", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/advs.202303246" } }, { "@type": "ScholarlyArticle", "name": "Cellular Senescence as a Brake or Accelerator for Oncogenic Transformation and Role in Lymphatic Metastasis.", "datePublished": "2023-02-02", "url": "https://questionsmedicales.fr/article/36769195", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24032877" } }, { "@type": "ScholarlyArticle", "name": "Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis.", "datePublished": "2023-08-10", "url": "https://questionsmedicales.fr/article/37573226", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.it.2023.07.002" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "4H-1-Benzopyran-4-ones", "item": "https://questionsmedicales.fr/mesh/D002867" }, { "@type": "ListItem", "position": 7, "name": "Flavonoïdes", "item": "https://questionsmedicales.fr/mesh/D005419" }, { "@type": "ListItem", "position": 8, "name": "Catéchine", "item": "https://questionsmedicales.fr/mesh/D002392" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Catéchine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Catéchine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Catéchine", "description": "Comment mesurer les niveaux de catéchines dans le corps ?\nQuels tests sont utilisés pour évaluer l'impact des catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Lymphatic+Metastasis#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Catéchine", "description": "Quels sont les effets secondaires des catéchines ?\nLes catéchines provoquent-elles des allergies ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Lymphatic+Metastasis#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Catéchine", "description": "Les catéchines aident-elles à prévenir les maladies cardiaques ?\nComment intégrer les catéchines dans l'alimentation ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Lymphatic+Metastasis#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Catéchine", "description": "Les catéchines peuvent-elles traiter des maladies ?\nComment les catéchines aident-elles à la perte de poids ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Lymphatic+Metastasis#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Catéchine", "description": "Les catéchines peuvent-elles interagir avec des médicaments ?\nQuels risques sont associés à une consommation excessive de catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Lymphatic+Metastasis#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Catéchine", "description": "Qui devrait éviter les catéchines ?\nLes femmes enceintes peuvent-elles consommer des catéchines ?", "url": "https://questionsmedicales.fr/mesh/D002392?mesh_terms=Lymphatic+Metastasis#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer les niveaux de catéchines dans le corps ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les niveaux de catéchines peuvent être mesurés par des analyses sanguines ou urinaires." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'impact des catéchines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cliniques et des études d'observation sont utilisés pour évaluer leur impact." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des catéchines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des maux d'estomac, des nausées ou des maux de tête." } }, { "@type": "Question", "name": "Les catéchines provoquent-elles des allergies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les allergies aux catéchines sont rares, mais peuvent survenir chez certaines personnes." } }, { "@type": "Question", "name": "Les catéchines aident-elles à prévenir les maladies cardiaques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent réduire le risque de maladies cardiaques en améliorant la santé vasculaire." } }, { "@type": "Question", "name": "Comment intégrer les catéchines dans l'alimentation ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Consommer du thé vert, des fruits et des légumes riches en catéchines est recommandé." } }, { "@type": "Question", "name": "Les catéchines peuvent-elles traiter des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont étudiées pour leur potentiel dans le traitement de maladies comme le cancer." } }, { "@type": "Question", "name": "Comment les catéchines aident-elles à la perte de poids ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent augmenter le métabolisme et favoriser la combustion des graisses." } }, { "@type": "Question", "name": "Les catéchines peuvent-elles interagir avec des médicaments ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent interagir avec certains médicaments, notamment les anticoagulants." } }, { "@type": "Question", "name": "Quels risques sont associés à une consommation excessive de catéchines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une consommation excessive peut entraîner des problèmes hépatiques ou des troubles digestifs." } }, { "@type": "Question", "name": "Qui devrait éviter les catéchines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des problèmes hépatiques ou des allergies doivent être prudentes." } }, { "@type": "Question", "name": "Les femmes enceintes peuvent-elles consommer des catéchines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles doivent consulter un médecin avant de consommer des catéchines en grande quantité." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 08/02/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Jae Sik Yu

2 publications dans cette catégorie

Affiliations :
  • School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
Publications dans "Catéchine" :

Ki Hyun Kim

2 publications dans cette catégorie

Affiliations :
  • School of Pharmacy, Sungkyunkwan University, Suwon 16419, Korea.
Publications dans "Catéchine" :

Masaharu Shin-Ya

2 publications dans cette catégorie

Affiliations :
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Department of Molecular Anti-Virus Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Eriko Ohgitani

2 publications dans cette catégorie

Affiliations :
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masaya Kawamoto

2 publications dans cette catégorie

Affiliations :
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Masaki Ichitani

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Anti-Virus Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Central Research Institute, ITO EN, Ltd, Shizuoka, Japan.

Makoto Kobayashi

2 publications dans cette catégorie

Affiliations :
  • Central Research Institute, ITO EN, Ltd, Shizuoka, Japan.

Takanobu Takihara

2 publications dans cette catégorie

Affiliations :
  • Central Research Institute, ITO EN, Ltd, Shizuoka, Japan.

Hitoshi Kinugasa

2 publications dans cette catégorie

Affiliations :
  • Central Research Institute, ITO EN, Ltd, Shizuoka, Japan.

Osam Mazda

2 publications dans cette catégorie

Affiliations :
  • Department of Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan. mazda@koto.kpu-m.ac.jp.
  • Department of Molecular Anti-Virus Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan. mazda@koto.kpu-m.ac.jp.

Chang Liu

2 publications dans cette catégorie

Affiliations :
  • Tea Science Society of China, Hangzhou, China.
Publications dans "Catéchine" :

Jian-Hui Ye

2 publications dans cette catégorie

Affiliations :
  • Tea Research Institute, Zhejiang University, Hangzhou, China.
Publications dans "Catéchine" :

Penghui Li

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Ailing Liu

2 publications dans cette catégorie

Affiliations :
  • College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Wenjun Xiao

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Jianan Huang

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Sheng Zhang

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Zhonghua Liu

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Tea Science of Ministry of Education, Hunan Agricultural University, Changsha, Hunan, China.
  • National Research Center of Engineering Technology for Utilization of Functional Ingredients from Botanicals, Collaborative Innovation Centre of Utilisation of Functional Ingredients from Botanicals, Hunan Agricultural University, Changsha, Hunan, China.
Publications dans "Catéchine" :

Zvezdelina Yaneva

2 publications dans cette catégorie

Affiliations :
  • Chemistry Unit, Department of Pharmacology, Animal Physiology and Physiological Chemistry, Faculty of Veterinary Medicine, Students Campus, Trakia University, 6000 Stara Zagora, Bulgaria.
Publications dans "Catéchine" :

Donika Ivanova

2 publications dans cette catégorie

Affiliations :
  • Chemistry Unit, Department of Pharmacology, Animal Physiology and Physiological Chemistry, Faculty of Veterinary Medicine, Students Campus, Trakia University, 6000 Stara Zagora, Bulgaria.
Publications dans "Catéchine" :

Sources (10000 au total)

Radiomics model based on features of axillary lymphatic nodes to predict axillary lymphatic node metastasis in breast cancer.

Breast cancer (BC) is among the most common cancers worldwide. Machine learning-based radiomics model could predict axillary lymph node metastasis (ALNM) of BC accurately.... The purpose is to develop a machine learning model to predict ALNM of BC by focusing on the radiomics features of axillary lymphatic node (ALN).... A group of 398 BC patients with 800 ALNs were retrospectively collected. A set of patient characteristics were obtained to form clinical factors. Three hundred and twenty-six radiomics features were e... Among the 800 cases of ALNs, there were 388 cases of positive metastasis (48.50%) and 412 cases of negative metastasis (51.50%). The baseline clinical model achieved the performance with an AUC = 0.89... Combinations of feature selection methods and machine learning-based classification algorithms can develop promising predictive models to predict ALNM in BC using CECT features. The combined model of ...

Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.

Endothelial-mesenchymal transition (EndoMT) is an emerging adaptive process that modulates lymphatic endothelial function to drive aberrant lymphatic vascularization in the tumour microenvironment (TM... Immunofluorescent staining of α-SMA, LYVE-1 and DAPI were examined in primary tumour samples obtained from 57 CSCC patients. Assessment of cytokines secreted by CAFs and normal fibroblasts (NFs) was p... CAF-derived PAI-1 promoted the EndoMT of LECs in CSCC. LECs undergoing EndoMT could initiate tumour neolymphangiogenesis that facilitated cancer cell intravasation/extravasation, which in turn promote... Our data indicate that CAF-derived PAI-1 acts as an important neolymphangiogenesis-initiating molecular during CSCC progression through modulating the EndoMT of LECs, resulting in promotion of metasta...

Overexpression of SATB1 correlates with epithelial-mesenchymal transition and lymphatic metastasis in gastric cancer.

Gastric cancer (GC) is a malignant tumor with a high mortality rate, and lymphatic metastasis is the main mode of GC metastasis. The nuclear transcriptional regulatory protein SATB1 has been confirmed... Epithelial-mesenchymal transition (EMT) is known as the pivotal process of GC metastasis. To evaluate the relationship between SATB1 and EMT in GC metastasis, the immunohistochemical method was used t... Abnormal positive expression of SATB1 protein in paraffin-embedded tumor tissues was positively correlated with local invasion, lymph node metastasis, and TNM staging in gastric cancer. There was a st... The GC patients with overexpression of SATB1 tended to have advanced stage and lymph node metastasis. SATB1 was positively correlated with EMT in Gastric Cancer....

A Visualized Dynamic Prediction Model for Lymphatic Metastasis in Ewing's Sarcoma for Smart Medical Services.

This study aims to predict the lymphatic metastasis in Ewing's sarcoma (ES) patients by nomogram. The risk of lymphatic metastasis in patients with ES was predicted by the built model, which provided ... A total of 929 patients diagnosed with ES were enrolled from the year of 2010 to 2016 in the Surveillance, Epidemiology, and End Results (SEER) database. The nomogram was established to determine pred... In this study, the nomogram was established based on six significant factors (survival time, race, T stage, M stage, surgery, and lung metastasis), which were identified for lymphatic metastasis in ES... In this study, we constructed and developed a nomogram with risk factors to predict lymphatic metastasis in ES patients and validated accuracy of itself. We found T stage (Tx OR = 2.540, 95%CI = 1.433...

HSP90AA1 promotes lymphatic metastasis of hypopharyngeal squamous cell carcinoma by regulating epithelial-mesenchymal transition.

Lymphatic metastasis (LM) emerges as an independent prognostic marker for hypopharyngeal squamous cell carcinoma (HSPSCC), chiefly contributing to treatment inefficacy. This study aimed to scrutinize ... In a preceding investigation, HSP90AA1, a differential gene, was discovered through transcriptome sequencing of HPSCC tissues, considering both the presence and absence of LM. Validation of HSP90AA1 e... HSP90AA1 is substantially up-regulated in HPSCC with LM and is identified as an independent prognostic risk determinant. The down-regulation of HSP90AA1 can achieve inhibition of tumor cell proliferat... HSP90AA1, by controlling EMT, can foster LM in HPSCC.This finding sets the foundation for delving into new therapeutic targets for HPSCC....